Logo

Tripos Shares Slide 9.37 On Weak Q4 Revenues

Mar 06, 2006

NEW YORK, March 6 (GenomeWeb News) - Tripos shares were down 9.37 percent, or $.31, in afternoon trade after Tripos announced a 20-percent slip in revenues for the fourth quarter and a net loss of $5.2 million.

 

As GenomeWeb News reported this morning, the company attributed the fall-off to the winding down of a four-year, $90 million file enrichment project with Pfizer.

Breaking News
The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.